Here are five key notes:
1. Silver Bullet Therapeutics is a privately-held medical device company based in San Jose, Calif. The new patent is for “coating for the controllable release of antimicrobial metal ions” and “bone implant and systems that controllably releases silver.”
2. The company expects to make their OrthoFuzlon Antimicrobial Bone Screw System commercially available to select institutions in Europe this fall.
3. The company’s approach to adding antimicrobial capabilities to new and existing medical device implants doesn’t require external power sources and doesn’t use drugs or other pharmaceutical agents.
4. The technology is designed for durability to withstand abrasive forces of screwing into bone.
5. Silver Bullet Therapeutics’ IP portfolio is expanding the use of antimicrobial technology on a broad range of medical devices and implants, including orthopedic screws, hip and knee prostheses, cardiac implantable defibrillators and pacemakers.
More articles on orthopedic devices:
BoneScalpel workshop attracts large crowd
6 things to know about the US spine device
ChoiceSpine receives ISO certification
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
